TP53 and neoplasm: TXNRD1 participated in activating the p53 tumor suppressor and promoting other tumor suppressor activities [33], and its downregulation by specific carcinogenic electrophilic compounds resulted in altering some of the cell’s malignancy phenotypes [34].